This tool is donation based and free. 🙏 We're looking for donations to keep it running — $360/year covers our server costs.

$18 of $360 · 5%
Donate

Has research found a cure for Alzheimer's diseace...

“has research found a cure for Alzheimer's diseace”
No cure yet
Confidence: High Checked on August 23, 2026

Summary

Research has not produced a cure for Alzheimer’s disease in humans. Recent studies show promising advances—such as reversal of disease in mouse models and early trial benefits—but no treatment has been proven to fully cure the condition. Claims of an existing cure are unfounded.

Sources 59 searched

nature.com
cell.com
thelancet.com
  • Treatment for Alzheimer's disease - The Lancet

    Although these pharmacological and non-pharmacological strategies have significantly improved health outcomes for patients with Alzheimer's disease, many lack stringent evidence of efficacy.

pubmed.ncbi.nlm.nih.gov
  • Alzheimer's disease drug development pipeline: 2026 - PubMed

    Introduction: Discovery and development of new therapies for Alzheimer's disease (AD) are urgently needed to address the world's growing population of individuals on the AD pathophysiological continuum. Clinicaltrials.gov is a resource for studying drugs in development for treatment of AD. Results: There are currently 158 drugs in 192 AD trials.

science.org
  • Alzheimer's Clinical Trial Results, Sadly Running True to Form | Science | AAAS

    Studies of thousands of patients with early cognitive impairment who took an oral form of semaglutide (Rybelsus, currently approved as a diabetes therapy) did not show improvements in mental function as compared to placebo. The company says that the treatment group showed “improvement of Alzheimer’s disease-related biomarkers” in both trials, although it does not (as far as I can see) say what those biomarkers were.

factcheck.afp.com
ucl.ac.uk
  • Promising early results from Alzheimer's trial targeting tau | UCL News

    Professor Mummery commented: “The CELIA data provide some of the clearest evidence that reducing tau pathology can translate into clinically meaningful benefit. “The magnitude of tau reduction and cognitive benefit observed in CELIA is among the most compelling reported to date in Alzheimer’s disease drug development and supports advancing diranersen to Phase 3 development.”

case.edu

This fact check is free and donation-based. $1 powers ~30 fact-checks.

Donate $1 to support fact-checking

Check another fact